Siren, L.L.C. Oric Pharmaceuticals, Inc. Transaction History
Siren, L.L.C.
- $1.76 Trillion
- Q1 2025
A detailed history of Siren, L.L.C. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 1,007,575 shares of ORIC stock, worth $9.74 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
1,007,575
Previous 1,007,575
-0.0%
Holding current value
$9.74 Million
Previous $8.13 Billion
30.86%
% of portfolio
0.32%
Previous 0.36%
Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
143Shares Held
75.9MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$63.6 Million0.12% of portfolio
-
Nextech Invest Ag5.29MShares$51.1 Million7.95% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$51.1 Million6.85% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$46.7 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$38.7 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $383M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...